Focused on Life

Providing new therapies to care-givers for diseases that currently have few or no treatment options with the aim to improve the lives of those faced with rare diseases with high unmet medical needs.

FAQ

Q: Where is Gentium headquartered?

A: Gentium is headquartered in Villa Guardia, (Como), Italy.

Our mailing address is: Piazza XX Settembre, 2 – 22079 Villa Guardia, (Como)
Tel: +39 031 385 999

Q: When was Gentium founded?

A: We were originally formed in 1993 as Pharma Research S.r.l., an Italian private limited company. In December 2000, we changed from a private limited company to an Italian corporation. In July 2001, we changed our name to Gentium S.p.A.

Q: Where is Gentium incorporated?

A: Gentium is incorporated in the Republic of Italy.

Q: In what year did Gentium go public?

A: Gentium began trading on the American Stock Exchange as a public company on June 21, 2005.

Q: On which exchange is Gentium currently listed and what is the ticker symbol?

A: Gentium has American Depositary Shares (ADSs) quoted on the NASDAQ Global Market under the ticker symbol GENT.

Q: What is Gentium’s number of outstanding shares?

A: 14,956,317 (as of June 30, 2010)

Q: Can I buy share directly from Gentium?

A: No, Gentium does not have a direct share purchase program. You can purchase Gentium ADSs through your broker.

Q: Does Gentium pay dividends?

A: Gentium has never paid any cash dividends and we do not anticipate paying cash dividends in the foreseeable future.

Q: Does Gentium currently have a share repurchase program?

A: No

Q: What is Gentium's CUSIP number for its ADRs/ADSs traded on the Nasdaq Global Market?

A: The CUSIP for Gentium is 37250B104.

Q: When does Gentium’s fiscal year end?

A: Gentium’s fiscal year ends on December 31st.

Q: What is Gentium’s official accounting currency?

A: Gentium reports in Euros.

Q: What accounting convention does Gentium use?

A: Gentium adheres to the United States Generally Accepted Accounting Principles (US GAAP) for its financial statements filed with the SEC and prepares its local financial statements using Italian Generally Accepted Accounting Principles (Italian GAAP).

Q: Who are Gentium’s independent auditors?

A: Reconta Ernst & Young S.p.A.

Q: How many members of Gentium’s board of directors are independent?

A: Three of our directors, Gigliola Bertoglio, Glenn Cooper and Bobby Sandage, Jr., meet the independence requirements of Nasdaq Listing Rule 5605 and the heightened independence requirements for Audit Committee members under Rule 10A-3 of the Securities and Exchange Act of 1934, as amended.

Q: Who is the chair of Gentium’s Audit Committee?

A: The audit committee is led by Gigliola Bertoglio. Ms. Bertoglio spent 23 years at Reconta Ernst & Young (the Italian affiliate of Ernst & Young LLP) where she was a partner and the head of the Capital Market Group in Italy. Ms. Bertoglio is a Certified Public Accountant in the United States and included in the Register of Authorized Auditors of Consob, the Italian Stock Exchange’s regulatory agency for public companies.

Q: How do I obtain a copy of your Financial Reports and/or Press Releases?

A: Our financial reports, press releases and SEC filings, which include our financial reports, can be found under the Annual Reports & SEC Filings and Press sections on our website or website. In addition, our SEC filings can be found on the SEC’s website at www.sec.gov.

Q: Who do I contact regarding lost stock certificates, address changes, and changes of ownership or name in which shares are held?

A: Please contact Salvatore Calabrese, Senior Vice President, Finance, at +39 031-385-287 or scalabrese@gentium.it.

Q: Can I subscribe to receive your news automatically?

A: Yes. Please complete the subscription form on our website to receive e-mail alerts each time something new is posted to the investor relations section of our website.